HSA — authorised 2 August 1990
- Marketing authorisation holder: GLAXOSMITHKLINE
- Status: likely_approved
🇸🇬 L-Dipalmitoyl Lecithin in Singapore
HSA authorised L-Dipalmitoyl Lecithin on 2 August 1990
Marketing authorisation
L-Dipalmitoyl Lecithin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Singapore
Frequently asked questions
Is L-Dipalmitoyl Lecithin approved in Singapore?
Yes. HSA authorised it on 2 August 1990.
Who is the marketing authorisation holder for L-Dipalmitoyl Lecithin in Singapore?
GLAXOSMITHKLINE holds the Singaporean marketing authorisation.